We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+1.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$19.4B
AUM Growth
+$60.4M
(+0.31%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
40.51%
Holding
261
New
8
Increased
55
Reduced
97
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$52.3M |
| 2 |
UnitedHealth
UNH
|
+$42.6M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$38.5M |
| 4 |
Broadridge
BR
|
+$35.7M |
| 5 |
Amazon
AMZN
|
+$32.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$110M |
| 2 |
Kraft Heinz
KHC
|
+$50.2M |
| 3 |
Plains All American Pipeline
PAA
|
+$43.7M |
| 4 |
Altria Group
MO
|
+$38.5M |
| 5 |
Constellation Brands
STZ
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.61% |
| 2 | Financials | 19.63% |
| 3 | Technology | 14.26% |
| 4 | Energy | 12.5% |
| 5 | Healthcare | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLXP
251
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $70K | ﹤0.01% |
13,729
| – | – |
|
|
ROX
252
DELISTED
Castle Brands, Inc.
ROX
| $67K | ﹤0.01% |
52,830
| – | – |
|
|
PR
253
Permian Resources
PR
$17.8B
| $60K | ﹤0.01% |
13,350
| – | – |
|
254
W&T Offshore
WTI
$534M
| $52K | ﹤0.01% |
11,858
| – | – |
|
255
General Motors
GM
$80.4B
| – | – |
-6,300
| Closed | -$243K |
|
256
HSBC
HSBC
$365B
| – | – |
-9,725
| Closed | -$406K |
|
257
NanoViricides
NNVC
$38.8M
| – | – |
-1,429
| Closed | -$7K |
|
|
FBSS
258
DELISTED
Fauquier Bankshares Inc
FBSS
| – | – |
-9,600
| Closed | -$205K |
|
|
CRR
259
DELISTED
Carbo Ceramics Inc.
CRR
| – | – |
-297,346
| Closed | -$401K |
|
|
APC
260
DELISTED
Anadarko Petroleum
APC
| – | – |
-2,883
| Closed | -$203K |
|
|
CADE
261
DELISTED
Cadence Bancorporation
CADE
| – | – |
-9,850
| Closed | -$205K |
|
Similar funds
HF
Fayez Sarofim & Co's Q3 2019 Portfolio in Review
As of Q3 2019, Fayez Sarofim & Co held 261 positions worth $19.4B, up 0.31% from $19.3B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Fayez Sarofim & Co's Q3 2019 filing shows 8 new, 55 increased, 97 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,439 shares worth $2.92M. The largest sale was Enterprise Products Partners, an estimated $110M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- Fayez Sarofim & Co's largest Q3 2019 buy was Alibaba: 17,439 shares worth $2.92M.
- Fayez Sarofim & Co added most to Progressive in Q3 2019, an estimated $52.3M increase.
- Fayez Sarofim & Co's biggest Q3 2019 reduction was Enterprise Products Partners, cutting an estimated $110M.
- Fayez Sarofim & Co fully exited HSBC in Q3 2019, selling an estimated $406K.
- Fayez Sarofim & Co's ten largest holdings make up 41% of its $19.4B portfolio in Q3 2019.
- Fayez Sarofim & Co opened 8 new positions and closed 7 in Q3 2019.
- Fayez Sarofim & Co's portfolio value rose 0.31% quarter-over-quarter to $19.4B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2019, filed 13 Nov 2019.